These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16388902)

  • 1. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic activity of systemically delivered angiogenin in the SOD1
    Crivello M; O'Riordan SL; Woods I; Cannon S; Halang L; Coughlan KS; Hogg MC; Lewandowski SA; Prehn JHM
    Neuropharmacology; 2018 May; 133():503-511. PubMed ID: 29486168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
    Brooks KJ; Hill MD; Hockings PD; Reid DG
    NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Karlsson J; Fong KS; Hansson MJ; Elmér E; Csiszar K; Keep MF
    J Neurosurg; 2004 Jul; 101(1):128-37. PubMed ID: 15255263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Petri S; Kipiani K; Gardian G; Choi DK; Chen J; Calingasan NY; Schafer P; Muller GW; Stewart C; Hensley K; Beal MF
    J Neurosci; 2006 Mar; 26(9):2467-73. PubMed ID: 16510725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal methods to characterize the G93A mouse model of ALS.
    Miana-Mena FJ; Muñoz MJ; Yagüe G; Mendez M; Moreno M; Ciriza J; Zaragoza P; Osta R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):55-62. PubMed ID: 16036427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.
    Zhang X; Chen S; Li L; Wang Q; Le W
    Neuropharmacology; 2008 Jun; 54(7):1112-9. PubMed ID: 18436268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
    Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
    Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
    Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
    Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.
    Kim K; Moore DH; Makriyannis A; Abood ME
    Eur J Pharmacol; 2006 Aug; 542(1-3):100-5. PubMed ID: 16781706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis.
    Barnéoud P; Curet O
    Exp Neurol; 1999 Feb; 155(2):243-51. PubMed ID: 10072299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method comparison in monitoring disease progression of G93A mouse model of ALS.
    Zhou C; Zhao CP; Zhang C; Wu GY; Xiong F; Zhang C
    Amyotroph Lateral Scler; 2007 Dec; 8(6):366-72. PubMed ID: 17852023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis.
    Pompl PN; Ho L; Bianchi M; McManus T; Qin W; Pasinetti GM
    FASEB J; 2003 Apr; 17(6):725-7. PubMed ID: 12586733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.